Transplant-Eligible Patients

Treating Myeloma: Newly Diagnosed Transplant-Eligible Patients

Transplant-Eligible Patients in Multiple Myeloma

Definition of transplant-eligible patients

Multiple Myeloma Hub

Frontline treatment of transplant eligible patients with myeloma: current approach & future changes

VJHemOnc – Video Journal of Hematology & HemOnc

Myeloma Made Simple: Treatment for Patients Not Undergoing Transplant (Non-ASCT Transplant Eligible)

International Myeloma Foundation

Treatment approaches for transplant-eligible and transplant-ineligbile myeloma patients

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Madduri on Challenges in Transplant-Eligible Patients With Myeloma

Exciting ongoing trials in frontline transplant-eligible patients with multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Treating elderly, non-transplant eligible patients with MF

VJHemOnc – Video Journal of Hematology & HemOnc

Integrated Myeloma Management for Transplant-Eligible Patients

PeerView Oncology

The value of MRD testing in transplant-eligible patients

VJHemOnc – Video Journal of Hematology & HemOnc

The challenge of relapse in transplant-eligible & transplant-ineligible patients with BDPCN

VJHemOnc – Video Journal of Hematology & HemOnc

Transplant-Eligible Multiple Myeloma: Current Treatment

Dr. Braunstein on Considerations for Stem Cell Transplant Eligibility in Myeloma

Myeloma: Frontline Therapy for Transplant Eligible Patients

GRIFFIN updates: D-RVd vs RVd in transplant-eligible patients with newly diagnosed multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Case 2: Transplant-eligible patient with newly diagnosed myeloma

Should You Get a Stem Cell Transplant for Multiple Myeloma? What Patients Need to Know!

The Patient Story

Management of transplant-eligible myeloma patients in 2017

VJHemOnc – Video Journal of Hematology & HemOnc

How does the IFM2009 trial impact the current treatment of transplant-eligible patients?

Multiple Myeloma Hub